These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11256930)

  • 1. Anti leishmanial therapy--the changing scene.
    Iyer SR; Iyer RR
    J Assoc Physicians India; 1995 Mar; 43(3):234. PubMed ID: 11256930
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Yazdanpanah MJ; Azizi H; Suizi B
    Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic antifungal treatment in critically ill patients. A survey of a Cochrane review].
    Christensen S; Buhl M; Tønnesen EK
    Ugeskr Laeger; 2008 Jan; 170(1):36-9. PubMed ID: 18208713
    [No Abstract]   [Full Text] [Related]  

  • 4. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal nail infections.
    Crawford F; Ferrari J
    Clin Evid; 2005 Dec; (14):2036-43. PubMed ID: 16620479
    [No Abstract]   [Full Text] [Related]  

  • 6. Fungal toenail infections.
    Crawford F; Ferrari J
    Clin Evid; 2006 Jun; (15):2212-20. PubMed ID: 16973086
    [No Abstract]   [Full Text] [Related]  

  • 7. Candidiasis (vulvovaginal).
    Spence D
    Clin Evid; 2005 Dec; (14):2200-15. PubMed ID: 16620487
    [No Abstract]   [Full Text] [Related]  

  • 8. Candidiasis (vulvovaginal).
    Marrazzo J
    Clin Evid; 2003 Jun; (9):1980-93. PubMed ID: 15366173
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluconazole in visceral leishmaniasis.
    Jha BB
    Indian Pediatr; 1998 Mar; 35(3):268-9. PubMed ID: 9707883
    [No Abstract]   [Full Text] [Related]  

  • 10. Candidiasis (vulvovaginal).
    Spence D
    Clin Evid; 2003 Dec; (10):2044-57. PubMed ID: 15555192
    [No Abstract]   [Full Text] [Related]  

  • 11. Candidiasis at ICAAC.
    Barr D; Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of visceral leishmaniasis with fluconazole and allopurinol in a patient with renal failure.
    Colakoglu M; Yaylali GF; Colakoglu NY; Yilmaz M
    Scand J Infect Dis; 2006; 38(2):152-4. PubMed ID: 16449014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral fluconazole treatment for extensive cutaneous leishmaniasis in an 11-year-old child.
    Toubiana J; Armengaud JB; Dupouy Camet J; Gendrel D
    Pediatr Infect Dis J; 2006 Nov; 25(11):1083-4. PubMed ID: 17072139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility testing of Trichophyton rubrum by E-test.
    da Silva Barros ME; de Assis Santos D; Soares Hamdan J
    Arch Dermatol Res; 2007 May; 299(2):107-9. PubMed ID: 17333224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of ketoconazole in oriental sore in India.
    Singh S; Singh R; Sundar S
    J Chemother; 1995 Nov; 7 Suppl 4():202-3. PubMed ID: 8904156
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifungal treatment in sarcoidosis--a pilot intervention trial.
    Tercelj M; Rott T; Rylander R
    Respir Med; 2007 Apr; 101(4):774-8. PubMed ID: 16982183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.
    Rautemaa R; Richardson M; Pfaller M; Perheentupa J; Saxen H
    Scand J Infect Dis; 2008; 40(11-12):904-7. PubMed ID: 18651265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
    Schmid-Wendtner MH; Korting HC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
    Walmsley S; King S; McGeer A; Ye Y; Richardson S
    Clin Infect Dis; 2001 Jun; 32(11):1554-61. PubMed ID: 11340526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could risk assessment for non-albicans Candida improve empiric treatment for invasive candidiasis?
    Drew RH
    Ann Pharmacother; 2007 Apr; 41(4):690-2. PubMed ID: 17389669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.